LAG3

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
OR-2805OR-2805Phase 2 ClinicalOncoResponse IncSolid tumours; Leiomyosarcoma; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Liposarcoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyEarliest Brand NameEarliest Approval CountryEarliest IndicationEarliest Approval CompanyEarliest Approval DateIndicationClinical Trial
TetrachlorodecaoxideTCDO; WF-10; OXO-K993ApprovedNuvox Pharma LLCWF10, Oxoferin, ImmunokineThailandRhinitis, Allergic; Inflammationnull1997-01-01Diabetic Foot; HIV Infections; Rhinitis, Allergic; Inflammation
Details
  • Product Inquiry
  • Marketed Drug Information
  • Clinical Drug Information
Contact Us

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8